These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36695995)

  • 1. ASO Author Reflections: Prognostic Value of Tumor Deposits in Resected Pancreatic Ductal Adenocarcinoma.
    Hua J; Shi S
    Ann Surg Oncol; 2023 May; 30(5):3045. PubMed ID: 36695995
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma.
    Malleo G; Maggino L; Fernàndez-Del Castillo C; Salvia R
    Ann Surg Oncol; 2020 Oct; 27(10):3913-3914. PubMed ID: 32399766
    [No Abstract]   [Full Text] [Related]  

  • 3. ASO Author Reflections: The Need for Improvement of the 8th American Joint Committee on Cancer TNM Staging System for Resected Pancreatic Ductal Adenocarcinoma.
    Schouten TJ; Daamen LA; van Santvoort HC; Molenaar IQ
    Ann Surg Oncol; 2022 Sep; 29(9):6000-6001. PubMed ID: 35441304
    [No Abstract]   [Full Text] [Related]  

  • 4. ASO Author Reflections: Prognostic Index after Neoadjuvant Chemotherapy (PINC) in Pancreatic Ductal Adenocarcinoma as Novel Tumor Regression Grading System.
    Redegalli M; Schiavo Lena M
    Ann Surg Oncol; 2022 Jun; 29(6):3503. PubMed ID: 35187623
    [No Abstract]   [Full Text] [Related]  

  • 5. ASO Author Reflections: Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinoma of the Body and Tail.
    Kitamura K; Esaki M; Sone M; Sugawara S; Hiraoka N; Nara S; Ban D; Takamoto T; Mizui T; Shimada K
    Ann Surg Oncol; 2022 Oct; 29(11):7059-7060. PubMed ID: 35648319
    [No Abstract]   [Full Text] [Related]  

  • 6. ASO Author Reflections: Accurate Evaluation of Malignant Potential in Pancreatic Ductal Adenocarcinoma Using DUPAN-2 Level.
    Sumiyoshi T; Uemura K
    Ann Surg Oncol; 2024 Jul; 31(7):4697. PubMed ID: 38739237
    [No Abstract]   [Full Text] [Related]  

  • 7. ASO Author Reflections: Prognostic Value of the Preoperative Tumor Marker Index in Resected Pancreatic Ductal Adenocarcinoma: A Retrospective Single Institutional Study.
    Miyata T; Hayashi H; Baba H
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):903-904. PubMed ID: 32840745
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: Do Distinct Patterns of Recurrence Impact the Prognosis of Patients With Resected Pancreatic Ductal Adenocarcinoma?
    Groot VP; Wolfgang CL; He J
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):806-807. PubMed ID: 30298312
    [No Abstract]   [Full Text] [Related]  

  • 9. ASO Author Reflections: Pancreatic Invasion is a Crucial Independent Prognostic Factor in Duodenal Carcinoma.
    Nitta N; Ohgi K; Sugiura T; Okamura Y; Ito T; Yamamoto Y; Ashida R; Sasaki K; Uesaka K
    Ann Surg Oncol; 2020 Oct; 27(11):4561. PubMed ID: 32462525
    [No Abstract]   [Full Text] [Related]  

  • 10. ASO Author Reflections: Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: The Challenge of Minimal Residual Disease.
    Belfiori G; Crippa S; Falconi M
    Ann Surg Oncol; 2024 Jun; 31(6):4115-4116. PubMed ID: 38472672
    [No Abstract]   [Full Text] [Related]  

  • 11. ASO Author Reflections: Timing of Systemic Therapy and Postoperative Morbidity in Resectable Pancreatic Ductal Adenocarcinoma and Distal Cholangiocarcinoma.
    Macfie R; Cohen N
    Ann Surg Oncol; 2023 Aug; 30(8):5035. PubMed ID: 37179272
    [No Abstract]   [Full Text] [Related]  

  • 12. ASO Author Reflections: Rethinking Spleen Preservation in Patients with Body Pancreatic Ductal Adenocarcinoma.
    Hobeika C; Sauvanet A
    Ann Surg Oncol; 2024 Jul; 31(7):4691-4692. PubMed ID: 38649552
    [No Abstract]   [Full Text] [Related]  

  • 13. ASO Author Reflections: Postoperative Carbohydrate Antigen 19-9 Levels Become a Reliable Biomarker for Establishing Intensity-Stratified Adjuvant Treatments in Pancreatic Ductal Adenocarcinoma.
    Ariake K; Okada T; Tsuchiya H; Kuboki D; Maemura K; Ichikawa H; Tachibana T; Akazawa N; Abe T; Kakita T; Oikawa M; Tsuchiya T
    Ann Surg Oncol; 2024 Jan; 31(1):548-549. PubMed ID: 37907696
    [No Abstract]   [Full Text] [Related]  

  • 14. ASO Author Reflections: Estimation of Intraoperative Superior Mesenteric-Portal Vein Involvement in Pancreatic Ductal Adenocarcinoma on Preoperative CT-Radiomics Provides Better Performance.
    Zhou Y; Chen FM
    Ann Surg Oncol; 2023 Feb; 30(2):1217-1218. PubMed ID: 36350457
    [No Abstract]   [Full Text] [Related]  

  • 15. ASO Author Reflections: Potential Role of Circulating Biomarkers in Resected Pancreatic Adenocarcinoma.
    White MG; Tzeng CD
    Ann Surg Oncol; 2021 Aug; 28(8):4623-4624. PubMed ID: 33507452
    [No Abstract]   [Full Text] [Related]  

  • 16. ASO Author Reflections: R Status Is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma.
    Crippa S; Giannone F; Lena MS; Falconi M
    Ann Surg Oncol; 2021 Aug; 28(8):4613-4614. PubMed ID: 33586067
    [No Abstract]   [Full Text] [Related]  

  • 17. ASO Author Reflections: The Clinical Dilemma of Para-Aortic Dissection in Pancreaticoduodenectomy for Ductal Adenocarcinoma.
    Shen Z; Chen H; Ji Y; Wang W; Shen B
    Ann Surg Oncol; 2023 Mar; 30(3):1483-1484. PubMed ID: 36303081
    [No Abstract]   [Full Text] [Related]  

  • 18. ASO Author Reflections: Relationship Between Sarcopenia, Patient Prognosis, and Tumor-Infiltrating T Cells in Pancreatic Ductal Adenocarcinoma.
    Masuda S; Yamakawa K; Masuda A
    Ann Surg Oncol; 2023 Sep; 30(9):5788-5789. PubMed ID: 37166741
    [No Abstract]   [Full Text] [Related]  

  • 19. ASO Author Reflections: Neoadjuvant Chemoradiotherapy for Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Pancreatectomy Changes Body Composition Influencing Long-term Outcomes.
    Takaichi S; Tomimaru Y; Kobayashi S; Toya K; Sasaki K; Iwagami Y; Yamada D; Noda T; Takahashi H; Asaoka T; Tanemura M; Doki Y; Eguchi H
    Ann Surg Oncol; 2023 Apr; 30(4):2469-2470. PubMed ID: 36567385
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.
    Maire F; Hammel P; Terris B; Paye F; Scoazec JY; Cellier C; Barthet M; O'Toole D; Rufat P; Partensky C; Cuillerier E; Lévy P; Belghiti J; Ruszniewski P
    Gut; 2002 Nov; 51(5):717-22. PubMed ID: 12377813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.